Vaporox was formed to commercialize Vaporous Hyperoxia Therapy (VHT™), a patented and FDA-510K-cleared technology that represents a breakthrough in treating 9 different types of skin wounds, including diabetic foot ulcers (DFUs). This innovative technology has been shown to generate up to three times the healing of the standard of care for DFUs. For more information, visit www.vaporox.com.
Vaporox was formed to commercialize Vaporous Hyperoxia Therapy (VHT™), a patented and FDA-510K-cleared technology that represents a breakthrough in treating 9 different types of skin wounds, including diabetic foot ulcers (DFUs). This innovative technology has been shown to generate up to three times the healing of the standard of care for DFUs. For more information, visit www.vaporox.com.